camtom
API
Clients
Pricing
Sign inTry now→
camtom
All services operational

Products

  • TariffPro — Tariff Classification
  • Docs — Document Extraction
  • API for Developers

Resources

  • Blog
  • Academy
  • Ebooks
  • Client Stories
  • Use Cases
  • Tariff Classifier
  • Tariff Code Search
  • Tariff Fractions (MX)
  • HTS Codes (US)
  • Trade Glossary
  • Industries
  • MVE by industry
  • HTS Classification
  • Trade Corridors
  • Integrations & Apps
  • Import Costs
  • Tariffs by Country
  • HS Chapters
  • NOM Directory
  • Regulatory Alerts
  • ROI Calculator
  • CCTS Certification
  • Trade Report 2026
  • Colombia Guides
  • Best Tools
  • Case Studies
  • Tariff API
  • Trade Data

Company

  • About
  • Contact
  • Pricing
  • Security
  • Privacy Policy
  • Confidentiality Notice
  • Terms & Conditions
© 2026 Camtom Labs, LLC·
SocialinX▶f◎

Designed and built in San Francisco, CA

  1. Home
  2. /Classification by industry
  3. /Pharmaceuticals

HTS Classification by industry

HTS Classification for Pharmaceuticals

Pharmaceutical imports involve active pharmaceutical ingredients (APIs), finished dosage forms, biologics, and medical devices — each with distinct classification rules under Chapters 29, 30, and 90. The difference between a bulk chemical and a pharmaceutical preparation can mean 0% versus 6.5% duty. Camtom navigates INN names, dosage forms, and FDA regulatory classifications to find the optimal HTS code.

Classification challenges in your industry

1

Distinguishing between bulk APIs (Ch. 29) and dosage-form preparations (Ch. 30) when the product is partially formulated

2

Classifying combination drugs that contain multiple active ingredients under the correct subheading

3

Navigating the pharmaceutical appendix (HTS General Note 13) for duty-free eligibility on INN-listed compounds

4

Determining whether diagnostic kits classify as reagents (3822) or instruments (9027)

5

Handling biologics and biosimilars that do not fit neatly into traditional chemical classification categories

Common classification mistakes

1

Classifying a finished tablet under Chapter 29 (organic chemicals) instead of 3004 (medicaments in measured doses)

2

Missing duty-free treatment for INN-listed APIs that qualify under the pharmaceutical appendix

3

Classifying veterinary pharmaceuticals under human pharma subheadings — Chapter 30 separates these

4

Treating a medical device accessory as a pharma product when it should go under Chapter 90

5

Failing to declare the dosage form (capsule, injectable, topical) which drives the 6-digit classification

Key HTS chapters

Chapter 30 — Pharmaceutical products
Chapter 29 — Organic chemicals
Chapter 28 — Inorganic chemicals
Chapter 38 — Chemical products n.e.s.
Chapter 90 — Optical/medical instruments
Chapter 39 — Plastics (packaging, devices)

Duty rate range

Many APIs enter duty-free under the Pharmaceutical Appendix (General Note 13). Finished dosage forms under 3004 face 0% to 6.5% depending on formulation. Medical devices under Chapter 90 range from 0% to 2.5%.

Rules of origin

Under USMCA, pharmaceutical products qualify for preferential treatment when they undergo a tariff shift from Chapter 29 (API) to Chapter 30 (finished drug) within a USMCA country. Biologics produced in USMCA countries generally qualify. Certificate of origin or importer certification is required.

Try now→Schedule a call→

Frequently asked questions